Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Division of Gynaecology, Department of the Woman, The Child and the Adolescent, Geneva University Hospitals, 30 Bld de la Cluse, 1211, Geneva, Switzerland.
Reprod Health. 2022 May 2;19(1):104. doi: 10.1186/s12978-022-01411-z.
Female genital mutilation/cutting (FGM/C) can result in short and long-term complications, which can impact physical, psychological and sexual health. Our objective was to obtain descriptive data about the most frequent health conditions and procedures associated with FGM/C in Swiss university hospitals inpatient women and girls with a condition/diagnosis of FGM/C. Our research focused on the gynaecology and obstetrics departments.
We conducted an exploratory descriptive study to identify the health outcomes of women and girls with a coded FGM/C diagnose who had been admitted to Swiss university hospitals between 2016 and 2018. Four of the five Swiss university hospitals provided anonymized data on primary and secondary diagnoses coded with the International Classification of Diseases (ICD) and interventions coded in their medical files.
Between 2016 and 2018, 207 inpatients had a condition/diagnosis of FGM/C. The majority (96%) were admitted either to gynaecology or obstetrics divisions with few genito-urinary and psychosexual conditions coded.
FGM/C coding capacities in Swiss university hospitals are low, and some complications of FGM/C are probably not diagnosed. Pregnancy and delivery represent key moments to identify and offer medical care to women and girls who live with FGM/C.
This cross-sectional study (protocol number 2018-01851) was conducted in 2019, and approved by the Swiss ethics committee.
女性外阴残割/切割(FGM/C)可导致短期和长期并发症,影响身体、心理和性健康。我们的目的是获得有关在瑞士大学医院住院的 FGM/C 女性和女孩的最常见与 FGM/C 相关的健康状况和程序的描述性数据。我们的研究集中在妇科和产科部门。
我们进行了一项探索性描述性研究,以确定在 2016 年至 2018 年间在瑞士大学医院住院的患有 FGM/C 编码诊断的女性和女孩的健康结果。五家瑞士大学医院中的四家提供了关于主要和次要诊断的匿名数据,这些诊断编码为国际疾病分类(ICD)和他们医疗档案中的干预措施编码。
在 2016 年至 2018 年间,有 207 名住院患者患有 FGM/C 状况/诊断。大多数(96%)被收入妇科或产科病房,编码的生殖泌尿系统和性心理健康状况很少。
瑞士大学医院的 FGM/C 编码能力较低,一些 FGM/C 的并发症可能未被诊断。怀孕和分娩是识别和为患有 FGM/C 的女性和女孩提供医疗保健的关键时刻。
这项横断面研究(方案编号 2018-01851)于 2019 年进行,并获得了瑞士伦理委员会的批准。